DECISION OF THE EEA JOINT COMMITTEE

No 159/2013

of 8 October 2013

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98 thereof,

Whereas:

(1)

Directive 2011/62/EU of the European Parliament and of the Council of 8 June 2011 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use, as regards the prevention of the entry into the legal supply chain of falsified medicinal products (1) is to be incorporated into the EEA Agreement,

(2)	Annex II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

The following indent is added in point 15q (Directive 2001/83/EC of the European Parliament and of the Council) of Chapter XIII of Annex II to the EEA Agreement:

‘—	32011 L 0062: Directive 2011/62/EU of the European Parliament and of the Council of 8 June 2011 (OJ L 174, 1.7.2011, p. 74).’

Article 2

The text of Directive 2011/62/EU in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

Article 3

This Decision shall enter into force on 9 October 2013, provided that all the notifications under Article 103(1) of the EEA Agreement have been made to the EEA Joint Committee (*1).

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 8 October 2013.

For the EEA Joint Committee

The President

Thórir IBSEN

(1) OJ L 174, 1.7.2011, p. 74.

(*1) Constitutional requirements indicated.